NASDAQ NMS - GLOBAL MARKET · SCTX
-13.30% · -$4.39 · Vol 528.8K
After hours · updated 18:52:50 ET
Scribe Therapeutics Inc

Scribe Therapeutics Inc

Biotechnology
$28.61
Card
Relationship Map

Follow $SCTX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $SCTX by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
SCTX
Scribe Therapeutics Inc
Mon Sep 21 · session closed · Markets closed · resumes Tue 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
Middle range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4 of 6 factors measured · Mon Sep 21 · session closed · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is SCTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading SCTX catalysts
About Scribe Therapeutics Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2026
Country
US

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$32.88
Day high
$34.49
Day low
$27.32
Previous close
$33.00
52W high
$37.25
-23.19% from high
52W low
$18.06
55% of range
Market cap
$624.7M
EPS
$-1.2407
Beta
-0.98
Shares out
18.9M
Volume
528.8K
1.77× rel vol
Avg volume
298.3K
VWAP
$28.59
Price history computed in-house
1W
-2.75%
1M
-16.17%
SMA 50 Not reported · Not reported
SMA 200 Not reported · Not reported
52W position 55%

SCTX overview

Veridion Score
59
Registered · 2026-09-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around SCTX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading SCTX Form 4 filings
Public disclosures

Congress activity in SCTX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for SCTX in the cached public ledger.

Federal contracts

SCTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for SCTX in this window.
Lobbying spend

SCTX lobbying filings, year to date.

Registered lobbying filings matched to Scribe Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for SCTX in this window.
Loading news for SCTX
Analyst ratings
Sovereign unlock shows live analyst consensus for SCTX.
Options
Sovereign unlock shows live options positioning for SCTX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.